🇺🇸 FDA
Patent

US 10828255

Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents

granted A61KA61K31/337A61K31/4709

Quick answer

US patent 10828255 (Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents) held by The Regents of the University of California expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/337, A61K31/4709, A61K31/7068, A61K31/7105